Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics
Saved in:
| Published in: | Discover Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics
- Cell-specific multi-target mechanisms of cotinine in cervical cancer oncogenesis and progression
- Integrated network pharmacology reveal new key curcumin-binding targets in triple-negative breast cancer
- Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer
- Network toxicology and molecular docking identify BRCA1 as a functional target of the dietary carcinogen PhIP in colorectal cancer
- Identification of hub mRNAs and long non-coding RNAs involved in temozolomide-resistant glioblastoma (brain cancer) cell lines
- Desmoglein 2 is associated with dihydroartemisinin resistance in HeLa cervical cancer cells: a potential link to the PI3K/AKT signaling pathway